Nishijima I, Nakahata T, Watanabe S, Tsuji K, Tanaka I, Hirabayashi Y, Inoue T, Arai K
Department of Molecular and Developmental Biology, Institute of Medical Science, The University of Tokyo, Minato-ku, Japan.
Blood. 1997 Aug 1;90(3):1031-8.
Using a clonal assay of bone marrow (BM) cells from transgenic mice (Tg-mice) expressing the human granulocyte-macrophage colony-stimulating factor receptor (hGM-CSFR), we found in earlier studies that hGM-CSF alone supported the development not only of granulocyte-macrophage colonies, but also of erythrocytes, megakaryocytes, mast cells, blast cells, and mixed hematopoietic colonies. In this report, we evaluated the in vivo effects of hGM-CSF on hematopoietic and lymphopoietic responses in the hGM-CSFR Tg-mice. Administration of this factor to Tg-mice resulted in dose-dependent increases in numbers of reticulocytes and white blood cells (WBCs) in the peripheral blood. Morphological analysis of WBCs showed that the numbers of all types of the cell, including neutrophils, eosinophils, monocytes, and lymphocytes increased; the most remarkable being in lymphocytes that contained a number of large granular lymphocytes (LGLs) in addition to mature T and B cells. However, total cellularity of the BM of the Tg-mice decreased in a dose-dependent manner when hGM-CSF was injected. In sharp contrast to the BM, spleens of the Tg-mice were grossly enlarged. Although all types of blood cells and hematopoietic progenitors increased in the spleen, erythroid cells and their progenitors showed the most significant increase. Increased numbers of megakaryocytes and LGLs were also observed in spleen and liver of the treated Tg-mice. Flow cytometric analysis showed that LGLs expanded in Tg-mice expressed Mac-1+ CD3- NK1.1+. The thymus of Tg-mice treated with hGM-CSF exhibited a dose-dependent shrinkage and a remarkable decrease in CD4+ CD8+ cells. Thus, hGM-CSF stimulated not only myelopoiesis but also erythropoiesis and megakaryopoiesis of hGM-CSFR Tg-mice in vivo, in accordance with our reported in vitro findings. In addition, hGM-CSF affected the development of lymphoid cells, including natural killer cells of these Tg-mice.
利用来自表达人粒细胞-巨噬细胞集落刺激因子受体(hGM-CSFR)的转基因小鼠(Tg小鼠)的骨髓(BM)细胞进行克隆分析,我们在早期研究中发现,单独的hGM-CSF不仅支持粒细胞-巨噬细胞集落的形成,还支持红细胞、巨核细胞、肥大细胞、原始细胞和混合造血集落的形成。在本报告中,我们评估了hGM-CSF对hGM-CSFR Tg小鼠造血和淋巴细胞生成反应的体内影响。向Tg小鼠施用该因子导致外周血中网织红细胞和白细胞(WBC)数量呈剂量依赖性增加。对WBC的形态学分析表明,包括中性粒细胞、嗜酸性粒细胞、单核细胞和淋巴细胞在内的所有类型细胞的数量均增加;最显著的是淋巴细胞,除了成熟的T细胞和B细胞外,还含有大量大颗粒淋巴细胞(LGL)。然而,当注射hGM-CSF时,Tg小鼠骨髓的总细胞数呈剂量依赖性下降。与骨髓形成鲜明对比的是,Tg小鼠的脾脏明显肿大。尽管脾脏中所有类型的血细胞和造血祖细胞都增加了,但红系细胞及其祖细胞的增加最为显著。在处理过的Tg小鼠的脾脏和肝脏中也观察到巨核细胞和LGL数量增加。流式细胞术分析表明,在Tg小鼠中扩增的LGL表达Mac-1+ CD3- NK1.1+。用hGM-CSF处理的Tg小鼠的胸腺呈现剂量依赖性萎缩,CD4+ CD8+细胞显著减少。因此,hGM-CSF不仅刺激了hGM-CSFR Tg小鼠体内的髓系造血,还刺激了红系造血和巨核系造血,这与我们之前报道的体外研究结果一致。此外,hGM-CSF影响了这些Tg小鼠包括自然杀伤细胞在内的淋巴细胞的发育。